Sohini Das

The reform booster shot that transformed India into pharmacy of the world

From generics to global leadership, India's pharmaceutical industry has transformed since 1991. Its next challenge is becoming a global hub for breakthrough drug innovation

Fermenta Biotech expands plant-based Vitamin D3 capacity at Dahej plant

Dahej facility to begin commercial production in FY28; company targets nutraceuticals, functional foods and import substitution

Camso, premium push put tyremaker Ceat on growth track; costs cloud FY27

Tyre maker expects premium products, exports and Camso integration to support growth, while higher raw-material costs, freight and geopolitical risks weigh on margins

Dr Reddy's antibiotic gets Thailand approval six months after US nod

Thailand has become the second country after the US to approve Dr Reddy's first-in-class antibiotic zoliflodacin, a milestone that could accelerate access to the drug across emerging markets

Electric car race widens as new entrants gain traction in H1 CY26

Maruti, VinFast and Tesla capture 8.1% market, account for 18% of incremental registrations

Maruti targets 25-30% growth in SUV sales in FY27 on new Brezza, launches

SUV contribution to Maruti Suzuki's domestic sales has risen from 12 per cent in FY23 to around 30 per cent in the first quarter of FY27

We can theoretically become net-debt zero after IPO: Manipal Health's Jose

MD & CEO Dilip Jose says the hospital chain will use the ₹8,000-crore fresh issue largely to repay debt, while pursuing organic expansion and selective acquisitions in key markets

Maruti repositions Brezza as first-time buyers reshape compact SUV market

The refreshed Brezza will target first-time, replacement and additional-car buyers as Maruti responds to changing preferences and intensifying competition in compact SUVs

Sona Comstar eyes 10x revenue growth with robotics, AI and acquisitions

The auto components maker aims to replicate the ten-fold growth achieved over the past decade, backed by robotics, physical AI, acquisitions and new mobility technologies

Trump's 200% tariffs on imported generic medicines to test India's edge

Imported generics to remain tariff-free for two years; industry doubts US can build a cost-competitive manufacturing ecosystem within the transition period

Bajaj Auto Q1 profit jumps 46% as record volumes and exports fuel growth

Bajaj Auto to raise annual production capacity to over 9 million vehicles

Q1FY27 pharma preview: Domestic growth cushions US-led pressure on earnings

Hospitals and diagnostics are expected to outperform in Q1FY27, driven by capacity additions, improving utilisation and higher patient volumes despite pressure on margins

Lupin spins out 2 cancer drug programmes into US-based Kaveri Therapeutics

New company to raise capital for global clinical trials; Lupin to retain significant equity stake and provide seed funding

Q1 results preview: Higher costs may squeeze margin of auto companies

OEM revenue is expected to rise 22-29 per cent in Q1FY27, led by strong vehicle demand, exports and premiumisation, while higher input and freight costs are likely to squeeze margins

MG unveils ADAPT platform, to launch EV and plug-in hybrid SUV during FY27

JSW MG Motor India says its new multi-powertrain ADAPT platform will underpin future new energy vehicles, with an electric SUV and a plug-in hybrid SUV slated for launch during FY27

Carmakers switch lanes to bring more software engineers on board

Trend leads to more women being employed on vehicle assembly lines

Govt releases draft CAFE 2027 norms, seeks stakeholder comments

Draft norms propose tighter fuel-efficiency targets from FY28 to FY32, compliance credits, super credits for cleaner vehicles and incentives for renewable fuels

SII to manufacture TB vaccine candidate under Gates MRI agreement

The agreement positions the Pune-based vaccine maker to manufacture the M72/AS01E TB vaccine candidate at scale if ongoing Phase III trials succeed and approvals are secured

Tata Motors seeks changes to draft CAFE norms over credit mechanism

Tata Motors has urged the Centre to revise draft CAFE norms, saying the proposed credit mechanism could make non-compliance cheaper than cleaner technology investments

Covering 'missing middle' can fix India's insurance gap: Sangita Reddy

NATHEALTH president also pitches prevention-led insurance, PPPs and a national mission to scale medical value travel